Chemesis Rolling Up High Value Cannabis Assets in United States


Robin Lefferts

October 5th, 2018

Exclusive, News, Top Story


As the United States lurches toward potential legalization of cannabis, companies looking for a place in the market are focused on the most lucrative legal markets in hopes of creating a business model that can eventually be replicated across the country. California is clearly the prized market, and that state’s legalization has been a bit of a mess as the state navigates a complicated transition from a mix of black market and legal medical operations to an industry that is fully regulated throughout the state.

One company that is taking advantage of the new California market is Chemesis International Inc. (CSE: CSI). Through a series of acquisitions, Chemesis now is positioned in the state with fully licensed facilities and brands focused on the highest value segments of the market. Chemesis represents a compelling investment opportunity in the burgeoning legal cannabis industry.

California Operations

Chemesis’ 80%-owned subsidiary SAP Global operates a fully licensed production facility in Cathedral City, California. At full production, the factory can put out 200 pounds of clean, consistent cannabis oil daily. On top of the interest in the production facility, Chemesis fully owns the California Sap line of retail cannabis-based products. The product line includes award-winning CO2 extracts, the innovative Gramqul packaging system for cannabis oil, and a line of vaporizers.  

In addition to its own line of products, SAP Global offers contract manufacturing of cannabis-derived products and white label production capabilities. This focus on extracts and associated products is central to Chemesis’ strategy in California. Industry-wide, consumer preferences are moving away from smoked flower and toward oils, concentrates, and alternative delivery methods that rely on extracts. On top of this trend, dried flower prices tend to drop significantly as legal markets mature, trimming margins for cultivators as the product becomes commoditized. To that end, Chemesis has chosen for the time being to not pursue cultivation assets in the state.

To complement its licensed production assets, Chemesis has acquired 100% of Desert Zen Fulfillment, a fully licensed cannabis manufacturing, packaging, and distribution operation based as well in Cathedral City, California. Desert Zen currently distributes a wide variety of products throughout the state. Its proximity to the SAP Global operations provides Chemesis a fully integrated operation in the Coachella Valley, one of the leading California regions in terms of creating a state-friendly regulatory environment for legal cannabis companies.

Other Initiatives

With an eye on lucrative international markets, Chemesis recently announced the opening of a wholly owned subsidiary called Chemesis Latin America. Reflective of Chemesis’ long term international growth strategy, the name of the subsidiary says it all in terms of market focus. Colombia, Peru, Chile, and Argentina all have recently passed medical cannabis laws, and Uruguay is the first country to decriminalize all drugs. Recognizing the potential of the market, Chemesis is actively seeking accretive opportunities there.

Chemesis is also looking to capitalize on another major trend in the cannabis industry. With investments pouring in to the emerging cannabis beverage sector, the company announced its intentions to develop and distribute cannabis beverages for both wholesale and retail markets. Leveraging the company’s production and distribution capabilities in Southern California, Chemesis anticipates launching initial products there in Q1 2019.  

Looking Ahead

Chemesis is anticipating revenues in the neighborhood of $27 million in the first full year of its California operations, producing a projected net income of about $8 million. Should the company execute on these projections, they would represent impressive financial accomplishments in an industry built, to this point, largely on potential. Keep an eye out for further developments as Chemesis executes on its comprehensive strategy, both in the US and internationally.

Disclaimer

The above article is sponsored content. Emerging Growth LLC, which owns CannabisFN.com and CFN Media, has been hired to create awareness. Please follow the link below to view our full disclosure outlining our compensation: https://www.cannabisfn.com/legal-disclaimer/

This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.

Avatar

About Robin Lefferts



Network Partners

Follow Us on Social Media

About CFN Media Group

CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.

Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.

Copyright © Accelerize Inc. · All Rights Reserved · Privacy Policy · Legal Disclaimer

loading